CCOc1cc(C(=O)OCC(=O)c2c(N)n(C)c(=O)n(C)c2=O)cc(OCC)c1OCC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?